Original Source(s)
Related Content
FDA approves FET-PET agent for glioma
The radioactive diagnostic drug is indicated in patients aged 1 month or older and is used in conjunction with other diagnostic evaluations.
September 14, 2026
-
2 min
Mandatory Training Modules Deserve a Harder Look
A JAMA Viewpoint argues that 4 million physician-hours spent on compliance modules each year warrants institutional reassessment.
by Kerri Miller
April 16, 2026
-
3 min
FDA Expands Gene Therapy for Younger Patients
Exagamglogene autotemcel is now indicated for patients aged 2 years and older with sickle cell disease and recurrent vaso-occlusive crises or transfusion-dependent beta thalassemia.
July 2, 2026
-
3 min